When was StoneWise founded?

StoneWise was founded in 2018 and raised its 1st funding round within a year of its incorporation.

Where is StoneWise located?

StoneWise is headquartered in Haidian, China.

Who is the current CEO of StoneWise?

Zhou Jielong of StoneWise. They have also founded 1 company.

How many employees does StoneWise have?

As of Jul 01, 2024, the latest employee count at StoneWise is 51 - 200.

Is StoneWise a funded company?

StoneWise is a funded company, having raised a total of $100M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2018.

When was the latest funding round of StoneWise?

StoneWise's latest funding was a $***** Series B round on Apr 12, 2021, with participation from 7 investors. Its primary sector is Life Sciences Tech. In China, the Life Sciences Tech sector has seen $531M in funding in 2026 to date.

Where does StoneWise rank among its competitors?

StoneWise ranks 7th amongst 90 active competitors, of which 19 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Metaphore, which secured an undisclosed amount in Aug, 2026.

Who are the top competitors of StoneWise?

StoneWise's top competitors include Metaphore, Tahoe Bio and Panakeia. Among them, Metaphore secured the most recent funding round in August, 2026.

StoneWise - 2026 Company Profile, Team, Funding & Competitors

StoneWise is a series B company based in Haidian (China), founded in 2018 by Zhou Jielong. It operates as a Provider of a software solution solution for molecular modeling. StoneWise has raised $100M in funding from investors like Legend Capital, Linear Venture and Long Hill Capital. The company has 90 active competitors, including 19 funded and 6 that have exited. Its top competitors include companies like Metaphore, Tahoe Bio and Panakeia.

Company Details

Stonewise provides a software solution for molecular modeling. It uses artificial intelligence-based technology for molecule design. It also gives the software for synthetic product prediction and drug knowledge mining.

Website: stonewise.cn
Email ID: *****@stonewise.cn

Key Metrics

Founded Year

2018

Location

Haidian, China

Stage

Series B

Total Funding

$100M in 4 rounds

Latest Funding Round

Series B, Apr 12, 2021, $*****

Investors

Legend Capital & 8 more

Ranked

7^th among 90 active competitors

Employee Count

51 - 200 as on Jul 01, 2024

Similar Companies

OpenEvidence & 2947 more

View StoneWise's full profile

StoneWise has raised a total funding of $100M over 4 rounds. Its first funding round was on 2018. Its latest funding round was a Series B round on Apr 12, 2021 for $*****. 7 investors participated in its latest round. StoneWise has 9 institutional investors.

Here is the list of recent funding rounds of StoneWise:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 12, 2021	3568093	Series B	9076292	4227377	2135855	8044819
Sep 09, 2020	3025687	Series A	1937917	8107711	6938539	Linear Venture
Mar 16, 2020	4387210	Series A	7881436	6050001	Long Hill Capital & 1 more	3191384

Access funding benchmarks and valuations. Sign up today!

View details of StoneWise's funding rounds and investors

The founders of StoneWise is Zhou Jielong. Zhou Jielong is the CEO of StoneWise.

Here are the details of StoneWise's key team members:

Zhou Jielong: Founder & CEO of StoneWise.
Contact Info: 1 email address

View details of StoneWise's Founder profiles and Board Members

StoneWise's employee count trend

StoneWise has 51 - 200 employees as of Jul 24. Here is StoneWise's employee count trend over the years:

Uncover StoneWise's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of StoneWise include Metaphore, Tahoe Bio and Panakeia. Here is the list of Top 10 competitors of StoneWise, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Metaphore 2021, Cambridge (United States), Series C	Provider of machine language and computational platform for drug discovery	$50M	Flagship Pioneering, TOHO HOLDINGS & 1 others	61/100
2nd	Tahoe Bio 2022, San Francisco (United States), Series B	Developer of AI models for drug design using single-cell maps.	$30M	Amplify Partners, Wing Venture Capital & 6 others	57/100
3rd	Panakeia 2018, London (United Kingdom), Seed	Provider of AI-based software for diagnosis and precision treatment	$4.04M	LocalGlobe, Entrepreneurs First & 6 others	57/100
4th	Algorithmic Biologics 2021, Bengaluru (India), Seed	Provider of software solutions for molecular diagnostics and discovery	$2.84M	Bharat Innovation Fund, Axilor Ventures & 3 others	47/100
5th	Physiomics 2001, Oxford (United Kingdom), Public	Provider of virtual tumour technology based solutions for pre-clinical and clinical development	-	Shackleton Ventures	43/100
6th	Paradigm4 2009, Waltham (United States), Series A	Clinical data management and analytic tools	-	Kepha Partners, Sigma Prime Ventures & 4 others	41/100
7th	StoneWise 2018, Haidian (China), Series B	Provider of a software solution solution for molecular modeling	$100M	Greater Bay Area Homeland Investments, Hillhouse ... & 7 others	41/100
8th	QuanMol Tech 2022, Canada, Seed	Provider of AI based solutions in molecular designing	$3M	Plug and Play Tech Center, Hat-Trick Capital ... & 3 others	40/100
9th	Valence Labs 2017, Montreal (Canada), Acquired	AI research engine focusing on advancing drug discovery through computational biology	$8.5M	Air Street Capital, Fifty Years & 17 others	38/100
10th	Digzyme 2019, Minato City (Japan), Series A	Digital molecular modelling tool for drug development	$4.72M	DG Daiwa Ventures, Plug and Play Tech Center ... & 6 others	35/100